CENTRAL NERVOUS SYSTEM DISEASES
Clinical trials for CENTRAL NERVOUS SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets brain inflammation to slow early Alzheimer's
Disease control CompletedThis study tested an experimental drug called XPro1595 in 208 people with early Alzheimer's who also had signs of brain inflammation. The goal was to see if the drug could improve thinking, memory, and daily function compared to a placebo. Researchers also checked for safety and …
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Can social media help prevent a second stroke?
Disease control CompletedThis study looked at whether using social networks (like WeChat) can help people at high risk for stroke take their medicines correctly and control risk factors after leaving the hospital. About 720 adults who had a stroke or were at high risk took part. The goal was to see if so…
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New Clot-Busting device shows promise for stroke patients
Disease control CompletedThis study tested a new device called the Supernova stent retriever to treat acute ischemic stroke, which happens when a blood clot blocks blood flow to the brain. The device is designed to remove the clot and restore blood flow. The trial involved 54 adults aged 18-85 who had a …
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Gravity Medical Technology, INC • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
Baby MRI dye study: is it safe for the tiniest patients?
Knowledge-focused CompletedThis study looked at how the contrast agent gadopiclenol behaves in the bodies of 36 infants and toddlers up to 23 months old who needed an MRI. Researchers measured drug levels and how quickly it left the body to understand safety and dosing. The goal was to gather information, …
Matched conditions: CENTRAL NERVOUS SYSTEM DISEASES
Phase: PHASE2 • Sponsor: Guerbet • Aim: Knowledge-focused
Last updated May 26, 2026 03:48 UTC